MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    GBA1 deficiency promotes the spread of Lewy pathology

    S. Fish, A. Park, J. Weiss, M. Kim, E. Chiu, M. Callier, S. Yu, M. Davis (Seattle, USA)

    Objective: To elucidate how GBA1 deficiency promotes the spread of Lewy pathology from cell to cell. Background: Mutations in the gene glucosidase, beta acid 1 (GBA1) not…
  • 2025 International Congress

    Combining Pharmaceutical and Digital Treatment Approaches in Parkinson’s Disease Modulates of the Limbic System, Supporting Emotional Regulation and Motivated Behaviors

    N. Saporta, M. Catalogna, T. Tamir, R. Sivan Hoffmann, A. Amedi (Ramat Gan, Israel)

    Objective: Following the combination of standard levodopa treatment with a digital intervention in Parkinson's disease (PD), we assessed the associations between neuroplasticity within the limbic…
  • 2025 International Congress

    Cerebello-Thalamo-Cortical Tract Microstructural Changes in Parkinson’s Disease Patients with Tremor

    I. Cruz, M. Wilken, G. álvarez, M. Villarreal, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate microstructural characteristics in the cerebello-thalamo-cortical circuit (CTC) of Parkinson's Disease (PD) patients with different tremor phenotypes. Background: Tremor is one of the…
  • 2025 International Congress

    Cholinergic activity associates with cognitive function in PD using [18F]VAT

    J. O'Donnell, A. Eid, H. Hwang, S. Grossen, J. Hood, E. Foster, Z. Tu, J. Perlmutter, M. Campbell (St. Louis, USA)

    Objective: To map the relationship between cholinergic activity in Parkinson Disease (PD) and cognitive performance and identify any differences in this relationship in cognitive impairment.…
  • 2025 International Congress

    Whole Genome Sequencing of an Early-onset Malaysian Parkinson’s Disease Cohort

    YW. Tay, TS. Toh, JW. Hor, JL. Lim, KA. Ibrahim, AS. Mawardi, TT. Lim, I. Looi, YK. Chia, JCE. Ooi, WC. Law, J. Wong, YH. Lau, PC. Teh, TL. Ong, WK. Cheah, LC. Lit, KA. Muthusamy, L. Lange, KL. Lohmann, ZH. Fang, CK. Klein, AA. Ahmad-Annuar, SY. Lim, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: To investigate the genetic causes of Malaysian early-onset Parkinson’s disease (EOPD) patients with whole genome sequencing (WGS). Background: EOPD (age of diagnosis ≤50 years)…
  • 2025 International Congress

    Inflammatory profile in LRRK2-associated prodromal and clinical PD:a cross-sectional study

    CC. Fan, JY. Liu, JH. Ma, XL. Liu, P. Chan, SY. Liu (Beijing, China)

    Objective: To investigate the peripheral inflammatory cytokine levels and their associations with clinical severity, dopaminergic presynaptic degeneration in asymptomatic carriers and PD patients with LRRK2 mutation.To investigate…
  • 2025 International Congress

    Smoking and Genetic Interactions in Parkinson’s Disease

    JDJ. Wang, LL. Chan, E. Ng, K. Prakash, WL. Au, L. Tan, EK. Tan (Singapore, Singapore)

    Objective: To investigate the interaction between smoking and Asian-specific LRRK2 variants (G2385R and R1628P) in Parkinson’s disease (PD) risk, examining whether smoking modifies the genetic…
  • 2025 International Congress

    A Case for Novel Phenotypes Associated with Digenic CHMP2B-LRRK2 Mutations

    D. Vijaywargiya, T. Chabrashvili (Liverpool, USA)

    Objective: We report a patient presenting with both bv-FTD & PD phenotypes, alongside a complex family history featuring multiple neurodegenerative disorders. Background: The CHMP2B &…
  • 2025 International Congress

    Building Genetic Counseling Capacity in Latin America: The PD GENEration–LARGE-PD Training Framework

    V. Caceres, R. de León, M. Inca Martinez, I F. Mata, A. Coral, P. Hodges (Indianapolis, USA)

    Objective: The PD GENEration (PD GENE) study has expanded into Latin America through collaboration with the Latin American Research Consortium on the GEnetics of Parkinson's…
  • 2025 International Congress

    Light-Based Therapy in Parkinson’s Disease: The Emerging Role of Optogenetics

    M. Helal, M. Gad, R. Eddin Haboush, A. Osman, M. Al-Jumaili, F. Wasia, G. Jamil, M. Elsayed (Zagazig, Egypt)

    Objective: This review explores the potential of optogenetics in Parkinson’s disease (PD) therapy, emphasizing its ability to address the limitations of current treatments like deep…
  • « Previous Page
  • 1
  • …
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley